Yersinia pestis, Yersinia pseudotuberculosis and Yersinia enterocolitica, utilize a plasmid encoded type III secretion system (T3SS) to promote infection by delivering Yersinia outer proteins (Yops) into the cytosol of mammalian cells. This T3SS is absolutely required for Yersinia virulence, which makes T3SS an attractive target in the development of novel therapeutics for treatment of plague and other Yersinia infections. In this study, a new method for high throughput screening (HTS) of small molecules for the ability to inhibit type III secretion (T3S) in Y. pestis has been developed. In comparison with screening assays employed by others, this method is very simple and rapid, and thus well suited for examining very large compound sets. Using this method, we screened a diverse collection of libraries at the US National Screening Laboratory. The initial examination of 70,966 compounds and mixtures from 13 libraries resulted in 431 primary hits. Strong positive indications of inhibition were observed at a rate of 0.01%, while moderate and weak but potentially meaningful signals were observed at rates of 0.056% and 0.54% respectively. Further characterizations were conducted on selected primary hits in Y. pestis. Of the eight compounds examined in secondary assays, four show good promise as leads for structure activity relationship studies. They are a diverse group, each having chemical scaffolds not only distinct from one another, but also distinct from previously described candidate T3S inhibitors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abe, A. (2002) Development of the screening system for the bacterial type III secretion appa-ratus inhibitor. Jpn. J. Antibiot. 55, 331-336.
Ben-Gurion, R. and Shafferman, A. (1981) Essential virulence determinants of different Yersinia species are carried on a common plasmid. Plasmid 5, 183-187.
Boland, A., Sory, M.P., Iriarte, M., Kerbourch, C., Wattiau, P. and Cornelis, G.R. (1996) Status of YopM and YopN in the Yersinia Yop virulon: YopM of Y.enterocolitica is internalized inside the cytosol of PU5-1.8 macrophages by the YopB, D, N delivery apparatus. EMBO J. 15, 5191-5201.
Cornelis, G.R. (2002) The Yersinia Ysc-Yop ‘type III’ weaponry. Nat. Rev. Mol. Cell Biol. 3, 742-752.
Ferber, D.M. and Brubaker, R.R. (1981) Plasmids in Yersinia pestis. Infect. Immun. 31, 839-841.
Gauthier, A., Robertson, M.L., Lowden, M., Ibarra, J.A., Puente, J.L. and Finlay, B.B. (2005) Transcriptional inhibitor of virulence factors in enteropathogenic Escherichia coli. Antim-icrob. Agents Chemother. 49, 4101-4109.
Hakansson, S., Schesser, K., Persson, C., Galyov, E.E., Rosqvist, R., Homble, F. and Wolf-Watz, H. (1996) The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity. EMBO J. 15, 5812-5823.
Higuchi, K., Kupferberg, L.L. and Smith, J.L. (1959) Studies on the nutrition and physiology of Pasteurella pestis. III. Effects of calcium ions on the growth of virulent and avirulent strains of Pasteurella pestis. J. Bacteriol. 77, 317-321.
Kauppi, A.M., Nordfelth, R., Uvell, H., Wolf-Watz, H. and Elofsson, M. (2003) Targeting bacterial virulence: inhibitors of type III secretion in Yersinia. Chem. Biol. 10, 241-249.
Linington, R.G., Robertson, M., Gauthier, A., Finlay, B.B., van Soest, R. and Andersen, R.J. (2002) Caminoside A, an antimicrobial glycolipid isolated from the marine sponge Caminus sphaeroconia. Org. Lett. 4, 4089-4092.
Mueller, C.A., Broz, P., Muller, S.A., Ringler, P., Erne-Brand, F., Sorg, I., Kuhn, M., Engel, A. and Cornelis, G.R. (2005) The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles. Science 310, 674-676.
Muschiol, S., Bailey, L., Gylfe, A., Sundin, C., Hultenby, K., Bergstrom, S., Elofsson, M., Wolf-Watz, H., Normark, S. and Henriques-Normark, B. (2006) A small-molecule inhibi-tor of type III secretion inhibits different stages of the infectious cycle of Chlamydia tra-chomatis. Proc. Natl. Acad.Sci. USA 103, 14566-14571.
Nordfelth, R., Kauppi, A.M., Norberg, H.A., Wolf-Watz, H. and Elofsson, M. (2005) Small-molecule inhibitors specifically targeting type III secretion. Infect. Immun. 73, 3104-3114.
Rosqvist, R., Forsberg, A. and Wolf-Watz, H. (1991) Intracellular targeting of the Yersinia YopE cytotoxin in mammalian cells induces actin microfilament disruption. Infect. Immun. 59, 4562-4569.
Rosqvist, R., Magnusson, K.E. and Wolf-Watz, H. (1994) Target cell contact triggers expres-sion and polarized transfer of Yersinia YopE cytotoxin into mammalian cells. EMBO J. 13, 964-972.
Wolf, K., Betts, H.J., Chellas-Gery, B., Hower, S., Linton, C.N. and Fields, K.A. (2006) Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle. Mol. Microbiol. 61, 1543-1555.
Zhang, J.H., Chung, T.D. and Oldenburg, K.R. (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen 4, 67-73.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Pan, N., Goguen, J., Lee, C. (2007). High Throughput Screening for Small-Molecule Inhibitors of Type III Secretion in Yersinia pestis. In: Perry, R.D., Fetherston, J.D. (eds) The Genus Yersinia. Advances In Experimental Medicine And Biology, vol 603. Springer, New York, NY. https://doi.org/10.1007/978-0-387-72124-8_34
Download citation
DOI: https://doi.org/10.1007/978-0-387-72124-8_34
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-72123-1
Online ISBN: 978-0-387-72124-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)